Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82072859)
Guangzhou Municipal Science and Technology Project (202102010292)
Basic and Applied Basic Research Foundation of Guangdong Province (2022A1515220127)
- License Information
-
More Information
Article History
Received: 13 November 2023
Accepted: 11 February 2024
First Online: 21 February 2024
Declarations
:
: The acquisition and use of human specimens were in concordance with the International Ethical Guidelines for Research Involving Human Subjects, as stated in the Helsinki Declaration, and were approved by the Medical Ethics Committee of Guangzhou Women and Children’s Medical Center (2022416B01). All the tissue samples were collected after obtaining signed informed consent from the participants. The use of ovarian cancer tissue microarray (TMA) was approved by the Ethics Committee of Shanghai Outdo Biotech Company (SHYJS-CP-1804010). All experiments involving animals were conducted according to the ethical policies and procedures approved by the Southern Medical University Animal Care and Use Committee (L-2020163).
: Not applicable.
: The authors declare that they have no competing interests. The authors alone are responsible for the content and writing of this article.
